RAHUL KHANNA
HOUSTON, TX
Browse related groups: TX ARGENX US, INC. All categories
This page merges CMS profile IDs: 7232637, 8800288 (associated profiles published by CMS for the same provider; see the provenance section below).
General Payments — all program years on this page
$36,959.11
- Category: General Payments
- Program years: PY2019–2024
- Record count: 162
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $21,925.45 across 60 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $21,045.00 | 7 |
| Food and Beverage | $863.73 | 52 |
| Education | $16.72 | 1 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ARGENX US, INC. | $21,079.00 | 9 |
| PFIZER INC. | $179.66 | 15 |
| HARMONY BIOSCIENCES LLC | $135.12 | 15 |
| E.R. Squibb & Sons, L.L.C. | $92.08 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $77.44 | 3 |
| JAZZ PHARMACEUTICALS INC. | $52.28 | 2 |
| LivaNova USA, Inc. | $43.80 | 2 |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $39.59 | 2 |
| ABBVIE INC. | $39.01 | 2 |
| Lundbeck LLC | $25.38 | 1 |
| GE HEALTHCARE | $24.72 | 1 |
| Neurocrine BioSciences, Inc. | $24.61 | 1 |
| Abbott Laboratories | $23.03 | 1 |
| Axsome Therapeutics, Inc. | $21.58 | 1 |
| Celgene Corporation | $21.02 | 1 |
| SK Life Science, Inc. | $16.83 | 1 |
| CATALYST PHARMACEUTICALS, INC. | $16.72 | 1 |
| Lilly USA, LLC | $13.58 | 1 |
By program year
Records — PY2024 (60)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
- Merged CMS profile IDs: 7232637, 8800288
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.